Biotech · Private company
Trefoil Therapeutics, Inc.
Track this companyFree. Adds Trefoil Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- TTHX1114Phase 2 · Corneal Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- TTHX1114(NM141)Phase 2 · Corneal Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- TTHX1114(NM141)Phase 2 · Fuchs' Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- TTHX1114(NM141) Ophthalmic SolutionPhase 1 · Corneal Epithelial DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Dose Escalation TTHX1114 Ophthalmic SolutionPHASE1 · COMPLETED · started Dec 6, 2022ClinicalTrials.gov NCT05769920 · fetched Nov 12, 2026
- A Safety and Efficacy Trial of TTHX1114 in People With CEDPHASE2 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT04812067 · fetched Nov 12, 2026
- TTHX1114(NM141) in Combination With DWEK/DSOPHASE2 · COMPLETED · started Feb 1, 2021ClinicalTrials.gov NCT04676737 · fetched Nov 12, 2026
- A Phase 1/ Phase 2 Study of TTHX1114(NM141)PHASE1_PHASE2 · COMPLETED · started Aug 19, 2020ClinicalTrials.gov NCT04520321 · fetched Nov 12, 2026